The Biden administration purchases an additional 200 million coronavirus disease 2019 (COVID-19) vaccine doses; the president plans to revoke Medicaid work requirements; companies seek billion-dollar tax deductions in opioid crisis settlement.
HHS and the Department of Defense (DOD) have purchased an additional 200 million doses of coronavirus disease 2019 (COVID-19) vaccines from Moderna and Pfizer, bringing the nation’s total combined purchase to 600 million doses. With the new total, the government now has the capacity to vaccinate 300 million people, while each company will deliver 300 million doses in regular increments through the end of July 2021, according to a statement. In the meantime, acting HHS Secretary Norris Cochran urged Americans to continue mitigation efforts, including wearing masks, washing hands, and practicing physical distancing. The 2 departments have contracted with 4 other companies to expedite development and production of additional vaccines.
The Biden administration plans to notify states today it is seeking to revoke Medicaid work requirements approved by former president Donald Trump, Politico reports. Democrats have been largely opposed to the measures, claiming the rules were illegal and set out to shrink health care coverage for poor adults. The new administration’s health department is expected to further unravel the work rules in the coming weeks, claiming that during the COVID-19 pandemic is not the time to test policies that risk substantial loss of health coverage or benefits. The measures, which were approved in a number of states, were allowed to mandate some people work or volunteer in order to be enrolled in Medicaid.
Although Cardinal Health, Johnson & Johnson, Amerisource Bergen, and McKesson all agreed to pay a combined $26 billion to settle claims regarding their roles in the opioid crisis, the 4 companies plan to deduct some of those costs from their taxes and regain around $1 billion each, according to a Washington Post analysis. Throughout recent months, the companies updated their financial projections to include tax benefits from the expected deal. Under the proposed settlement, each company would pay between $5 and $8 billion to reimburse communities affected by the opioid crisis. However, some feel the $26 billion is not enough to compensate for the epidemic’s financial toll and lets companies off the hook without an admission of guilt.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More